To assess whether granulocyte colony-stimulating factor ( G-CSF ) treatment induces a sustained benefit on adverse remodelling in patients with large anterior ST-elevation myocardial infarction ( STEMI ) and left ventricular ( LV ) dysfunction after successful reperfusion .